Navigation Links
Fingertip Formulary Analytics(R) Offers One-Click Access to Customized Formulary Data and Co-Pay Reports

GLEN ROCK, N.J., March 4 /PRNewswire/ -- Fingertip Formulary, the leading provider of access to and insight into US formulary data, introduces one-click access to customized formulary data and co-pay reports. Fingertip Formulary Analytics, the leading web-based formulary reporting platform, now offers subscribers the ability to save report selections for easy future access. The analytics platform offers eleven comprehensive reports that provide real-time current and historical data on formulary status, managed care restrictions, covered pharmacy lives, and co-pay levels. Data may be reviewed at the national, state, MSA, or county level with a few simple report selections and results are displayed immediately. Subscribers may run reports, with real-time results, for any type of plans and for any geographic area of interest. All reports offer results as a percentage of covered lives or a percentage of plans. The unique flexibility in the Fingertip Formulary Analytics platform provides for a virtually unlimited number of report queries which can be tailored to the precise needs of each subscriber.

With the new enhancement, users may save any number of report selections in a personalized list that can be accessed at any time. Results from stored reports are then immediately available with a single click. Subscribers may now easily setup the reports that are of greatest interest to them and easily access them on a going-forward basis.

"This enhancement demonstrates the ongoing value of Fingertip Formulary Analytics. Our customers can now access exactly what they need when they need it in one click. A simple-to-use platform just became that much easier to use," commented Mike Green, Senior Vice President, Sales and Business Development.

About Fingertip Formulary(R)

Fingertip Formulary (, the leading provider of access to and insight into formulary data in the United States offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others. The company offers a variety of unique data and marketing solutions for the pharmaceutical industry, consultants and healthcare providers that provide access to and insight into formulary data. Fingertip Formulary is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:
    Elizabeth Marshall
    Decision Resources, Inc.

SOURCE Decision Resources, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Fingertip Formulary Mobile(TM) is Now Available for Physicians and Other Healthcare Providers Free on PDAs
2. Fingertip Formulary Restrictions(TM) Provides Unprecedented Access to Real- Time Managed Care Restrictions Data
3. What gives us fingertip dexterity?
4. Encision Moves Power and Safety to Surgeons Fingertips
5. Advancing Interoperability - Nonin(R) Medical Unveils Worlds First Bluetooth(R)-Enabled, Wireless Fingertip Pulse Oximeter
6. Nonin(R) Medical Pioneers First Interoperable, Wireless Fingertip Pulse Oximeter
7. Health Information at Your Fingertips with the Dr Foster Website Launch
8. Equipping your Sales Force to Influence Hospital Formulary Decision-Makers
9. Safety Concerns Prompt Prime to Remove Avandia(R) from Formulary
10. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
11. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
Post Your Comments:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: